The markers support non-invasive early detection, and may help reliably distinguish between healthy individuals and those with cervical cancer
A study from Sun Yat-sen University in Guangzhou shows: Combination of the biomarkers Apo10 and TKTL1 reliably detects early-stage breast cancer – and is able to distinguish between malignant and benign tumors.
A study conducted by Sun Yat-sen University in Guangzhou provides initial evidence that the biomarkers Apo10 and TKTL1 can help detect lung cancer at an early stage and distinguish it from benign pulmonary nodules.
The KrebsScan cancer screening program combines the PanTum Detect® blood test with the strengths of imaging techniques (PET-CT/MRI).
Study shows with the help of PanTum Detect®: Significantly increased TKTL1 and DNasex (Apo10) levels in children and adolescents with rhabdomyosarcoma.
Tübingen researchers: PanTum Detect® blood test is able to distinguish between children / adolescents with neuroblastoma and healthy individuals.
Study shows: PanTum Detect® test paves the way for the targeted use of imaging methods for early cancer detection. (Press Release in german language)